GLP-1 drugs are life changing. But the science is clear: Without strength training, you’ll lose more than just weight.
HEALTH & WELLNESS MARCH 2026
If you’re taking a GLP-1 drug like Ozempic, Wegovy, or Mounjaro, you already know the appeal. The weight falls off. The desire subsides. You feel like the deck is finally stacked in your favor. And that’s it – they are really effective drugs.
But one thing is important: the weight you lose isn’t just fat. A significant portion may come from lean body mass, which includes muscle. Without strategies to maintain muscle mass, this can lead to reduced strength and functionality over time.
The good news? The solution doesn’t require hours in the gym. Short, consistent resistance exercises can help maintain muscle tone. Here’s what the research shows.
The hidden costs of GLP-1 weight loss
Studies on semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound) come to the same conclusion 25 to 40% of the weight lost with these medications is lean body mass – this also includes muscles. The groundbreaking STEP-1 trial of semaglutide found that about 40% of total weight loss came from lean tissue, not fat. This isn’t nothing.
25-40%
GLP-1 weight loss may be due to muscle mass, not fat
30%
potentially higher risk of osteoporosis in GLP-1 users compared to non-users
~1 out of 8
Adults in the US now take a GLP-1 drug
10 mins
Daily strength training can protect your muscles and bones
Why is this important? Muscle plays a key role in metabolic health, strength, mobility and long-term function. Loss of muscle mass can lead to fatigue, reduced strength and an increased risk of frailty over time.
New research: GLP-1 and bone risk
Some new research has examined possible effects of GLP-1 drugs on bone health. results are mixed and not final.Weight loss itself – regardless of the method – is associated with a reduction in bone density. Reduced calorie intake and lower mechanical stress contribute to this.
Exercise, particularly resistance and weight-bearing exercise, is one of the evidence-based methods to maintain bone density during weight loss.
Why resistance training is non-negotiable
Resistance training is one of the most effective ways to maintain muscle and bone during weight loss.
A randomized clinical trial published in JAMA Network Open (2024) found that the combination of GLP-1 therapy and exercise resulted in: better preservation of bone mineral density compared to GLP-1 therapy alone.
“It appears highly advisable to provide targeted exercise to maintain and potentially increase muscle mass in patients receiving GLP-1-based therapies.”
— Frontiers in Endocrinology, 2024
A separate case series published in PMC showed that GLP-1 users who completed structured resistance training three to five days per week not only gained muscle – some patients even increased their muscle mass while losing significant body fat. That’s the difference between losing weight and truly changing your body composition.
The conclusion of the research: The drug causes fat loss. You do the muscle maintenance.
This is where microdose workouts come into play
That’s the thing about people taking GLP-1 drugs: They’re often looking for the most effective, least strenuous route. That’s not criticism – it’s clever. These medications work precisely because they lower the threshold for success. Microdose workouts follow the same philosophy.
You don’t need a 60-minute gym session to protect your muscle mass. Research shows that short, frequent resistance exercises – even just 5 to 10 minutes at a time – stimulate the muscle-preserving response your body needs. A 2025 study from Edith Cowan University found that a daily 5-minute bodyweight workout helped improve strength, flexibility, and mood, even in people who rarely exercise.
“People taking GLP-1 drugs already have an appetite and fat burning tool. Strength training complements this by helping to maintain muscle.”
– Evidence-based consensus in exercise physiology research
Think of it as a combination of two efficiency tools: the drug provides the calorie reduction; The short daily training serves to maintain muscle and bone. Together they produce a result that no one can achieve alone.
What this can look like in your everyday life
GLP-1 friendly microdose resistance movements (5-10 minutes each)
- Wall or floor push-ups (3 sets of 10-15 reps) while making coffee
- Bodyweight squats or chair squats – great for quadriceps and glutes
- Work out with resistance bands or curls at your desk or in front of the TV
- Climbing stairs at a brisk pace – one of the most studied activities to protect bones
- Slow, controlled lunges during a phone call
- Plank Hold (20-30 seconds) – strengthens core muscles without the need for a gym
- Heel elevation when standing at the kitchen counter – protects ankle and calf muscles
You don’t need weights. You don’t need a gym membership. You need continuity and a little effort in the right direction. Just three or four of these “microdoses” per week can make a significant difference to your muscle and bone health over time.
The snack bar
GLP-1 drugs are an effective remedy. But tools work best when used correctly. The research is clear: Without some form of strength training, you risk losing the muscle and bone density you need to live a long, healthy life. And when it comes to microdose workouts, the bar couldn’t be lower.
Ten minutes. A few times a week. No gym required. Just as your medications require very little from you each week for a big reward, the same goes for this one.
The scale only tells you part of the story. Make sure the rest of the story is good.
The studies behind this article
- Bone health after exercise alone, treatment with GLP-1 receptor agonists, or combination treatment (JAMA Network Open, 2024) — RCT of 195 adults over 52 weeks. Exercise + GLP-1 therapy preserved hip, spine, and forearm bone density compared to GLP-1 therapy alone, resulting in reduced bone mineral density.
- Preservation of Lean Soft Tissue During Weight Loss With GLP-1 Therapies (PMC, 2025) – Case series showing that GLP-1 users who combined resistance training (3-5 days/week) with adequate protein either minimized muscle loss or actually increased soft tissue muscle mass while losing fat.
- GLP-1s May Increase Risk of Osteoporosis, New Research Finds (AAOS/NBC News, 2026) – A large retrospective study presented at the American Academy of Orthopedic Surgeons found that GLP-1 users had about 30% higher rates of osteoporosis and nearly twice the risk of bone mineral density problems over a five-year period.
- Muscle mass and GLP-1 receptor agonists: adaptive or maladaptive response? (Edition, 2024) – Comprehensive review from the Journal of the American Heart Association. Semaglutide was associated with a loss of muscle mass of up to 40% of total weight in the STEP 1 study; highlights the importance of targeted lifestyle interventions.
- GLP-1 and Lean Mass: What the Research Shows (ACE Fitness, 2025) – Analysis of a genetic study of more than 800,000 people confirming that GLP-1 reduces both fat and muscle mass, but fat loss is greater. Recommends strength training 2-3x per week and protein goals of 1.2-1.6g/kg/day to maintain muscle.
This article is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare team before changing your exercise program while taking any medication.
